News

Based on the FDA’s request for additional data and analyses, the company now expects that approval of its Andara OFS system for the treatment of acute spinal cord

Inovio will receive this milestone payment for its contribution to the collaboration, which has so far demonstrated the high level of gene delivery and expression that is thought

The co-primary endpoints for these studies will evaluate the differences between treatments in mean percent weight loss and in the percentage of subjects achieving weight loss of 5%

Carigent will apply the proceeds to further develop its nanotechnology platform, improve laboratory production capabilities and core expertise to support partnerships with pharmaceutical and biotechnology companies, and advance

Patient recruitment has started and several additional clinical centers are expected to start recruiting within the next few weeks. The trial remains on track for completion in 2008.

Phentermine hydrochloride (HCl) is indicated for the short-term management of obesity. The company expects to commence marketing this product immediately. Arthur Bedrosian, president and CEO of Lannett, said:

As a subset analysis of a larger double-blind trial, the study comparing Euflexxa and Synvisc demonstrated that an intra-articular hyaluronic acid (IA-HA) treatment for knee osteoarthritis (OA) is

The patent describes a method for detecting protein-protein interactions in living cells and animals. Protein interactions define the intricate biochemical networks in living cells, and are used at

The preclinical results demonstrated that ENMD-1198, administered as a single agent, is effective in significantly delaying the growth of leukemia xenografts in vivo. Combination studies with ENMD-1198 and